Currently the price is 8,29$, In this post we are going to talk about the listed company Oncternal Therapeutics Inc, its leaders are Gunnar F. Kaufmann (Chief Scientific Officer), James B. Breitmeyer (President, Chief Executive Officer & Director), Richard Glenn Vincent (Chief Financial Officer, Secretary & Treasurer), Salim Yazji (Chief Medical Officer), they lead it to work in Biotechnology: Pharmaceutical Preparations especially in the North America region.
Today this action begins with yesterday's closing price, desconocido$.
With an intraday difference of 8,16$ moving between 8,00$ and 8,32$, it is a notable difference that allows quick purchases and sales.
The company has an annual revenue of desconocido.
The last registered opening is of desconocido.
One of the most interesting values to assess whether the price of a share is low or high is the minimum and maximum price of the last 52 weeks, in this case it has varied between 0,00$ and 0,00$.
EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].
Buscar
